Filing Flows › BioAge Labs (BIOA) › Q2 2026 › vs Q1 2026
BioAge Labs (BIOA) Q2 2026 vs Q1 2026 (quarter over quarter)
BioAge Labs's revenue fell $321K (-12%) from $2.8M in Q1 2026 to $2.5M in Q2 2026.
BioAge Labs, Q2 2026: revenue $2.5M (+2% year over year), net loss $26.1M, operating cash flow −$19.3M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $2.5M | $2.8M | −$321K | -12% |
| Other income, net | $3.2M | $3.1M | $114K | +4% |
| Net loss | $26.1M | $22.3M | $3.8M | +17% |
| Costs & expenses | $31.8M | $28.1M | $3.6M | +13% |
| Operating costs | $31.8M | $28.1M | $3.6M | +13% |
| Research & development | $24.4M | $20.4M | $4.0M | +19% |
| General & admin | $7.4M | $7.7M | −$318K | -4% |
| Operating cash sources | $26.1M | $22.3M | $3.8M | +17% |
| Share-based compensation | $4.3M | $4.3M | $13K | +0.3% |
| Working capital & other | $2.6M | −$6.0M | $8.6M | — |
| Cash used in operations | $19.3M | $24.0M | −$4.8M | -20% |
| Net loss absorbed | $26.1M | $22.3M | $3.8M | +17% |
Questions
How much did BioAge Labs's revenue grow quarter over quarter in Q2 2026?
BioAge Labs's revenue fell $321K (-12%) from $2.8M in Q1 2026 to $2.5M in Q2 2026.